COVID ‐19 hospitalization outcomes in adults by HIV status ; a nation‐wide register‐based study
HIV Medicine · 2023
DOI: 10.1111/hiv.13515 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, 2023. Verfasst von Isabela Killander Möller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: COVID-19, HIV Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Landstinget Västmanland.
Abstract (Originalsprache)
Objectives
To assess the outcome of patients hospitalized with COVID‐19 by HIV status and risk factors for severe COVID‐19 in people living with HIV (PWH), we performed a nationwide cohort study using register data.
Methods
All people aged ≥18 years hospitalized with a primary COVID‐19 diagnosis (U07.1 or U07.2) in Sweden between February 2020 and October 2021 were included. The primary outcome was severe COVID‐19 [intensive care unit (ICU) admission or 90‐day mortality]. Secondary outcomes were days in hospital and ICU, complications in hospital, and risk factors for severe COVID‐19 in PWH. Regression analyses were performed to assess severe COVID‐19 by HIV status and risk factors.
Results
Data from 64 815 hospitalized patients were collected, of whom 121 were PWH (0.18%). PWH were younger ( p < 0.001), and larger proportions were men ( p = 0.014) and migrants ( p < 0.001). Almost all PWH had undetectable HIV‐RNA (93%) and high CD4 T‐cell counts (median = 560 cells/μL, interquartile range: 376–780). In an unadjusted model, PWH had statistically significant lower odds of severe COVID‐19 compared with patients without HIV [odds ratio (OR) = 0.6, 95% confidence interval (CI): 0.34–0.94], but there was no significant difference after adjusting for age and comorbidity (adjusted OR = 0.7, 95% CI: 0.43–1.26). A statistically significant lower proportion of PWH (8%, 95% CI: 5–15%) died within 90 days compared with those without HIV (16%, 95% CI: 15–16%, p = 0.024). There was no statistically significant difference in days in hospital and complications during the hospital stay between PWH and patients without HIV.
Conclusions
In this nationwide study including well‐treated PWH, HIV was not a risk factor in hospitalized patients for developing severe COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
- Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Clinical Sciences, Lund University, Lund, Sweden.
- Centre for Clinical Research Västmanland, Västmanland County Hospital, Uppsala University, Västerås, Sweden.
ORCID-Profile: Isabela Killander Möller, Christina Carlander
Förderung
- Landstinget Västmanland
Zitieren
APA
Möller, I. K., Gisslén, M., Wagner, P., Sparén, P., & Carlander, C. (2023). COVID ‐19 hospitalization outcomes in adults by HIV status ; a nation‐wide register‐based study. HIV Medicine. https://doi.org/10.1111/hiv.13515
Vancouver
Möller IK, Gisslén M, Wagner P, Sparén P, Carlander C. COVID ‐19 hospitalization outcomes in adults by HIV status ; a nation‐wide register‐based study. HIV Medicine. 2023. doi:10.1111/hiv.13515
BibTeX
@article{Mller2023,
author = {Möller, Isabela Killander and Gisslén, Magnus and Wagner, Philippe and Sparén, Pär and Carlander, Christina},
title = {COVID ‐19 hospitalization outcomes in adults by HIV status ; a nation‐wide register‐based study},
journal = {HIV Medicine},
year = {2023},
doi = {10.1111/hiv.13515}
}
EUVIMED